Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Notebook: Revolutionary Change Needed for European Biotech; CHMP Releases Opinions Agenda; Growing Interest In Biosimilars

Executive Summary

Radical change urged to help Europe compete in biotech; CHMP becomes less secretive over its meeting agendas; Almirall restructures its European business and buys U.S. dermatology business; biosimilar biologics companies, Almotech and Samsung Bioepis, target Europe.


Related Content

Clinical Trials Transparency: EMA Delay Gives Industry Initiative More Time To Take Root
Germany’s Grand Coalition Offers Pharma Little Certainty, Except For Continued Discounts
Bayer Chief: Pharma’s Bad Rep Puts Europe Drug Business Model At Risk
Algeta, Aspiring For Solo Success, Draws Bayer Bid After Xofigo Launch
GSK Negotiating Potential $1 Billion Sale Of Two Thrombosis Drugs To Aspen
Europe Transparency Initiatives May Aid Progress Toward Adaptive Licensing Systems
Europe’s Newest Biotech – Valneva – Formed As Intercell And Vivalis Marry
GSK Applauds U.K.'s Tax Changes, Announces New Jobs And Manufacturing Facilities


Related Companies

Related Deals




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts